Telesis Bio Inc. (TBIO) NASDAQ

$0.33 (0.05) (-12.90%)

Market Cap: $11.44M

As of 04/18/24 04:00 PM EDT. Market closed.

(TBIO)

Telesis Bio Inc. (TBIO)
NASDAQ

$0.33
(0.05) (-12.90%)

Market Cap: $11.44M

As of 04/18/24 04:00 PM EDT. Market closed.

Add to Portfolio

sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services ... read more

sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Analytical Laboratory Instrument Manufacturing
Full Time Employees
76
Address
.
PRICE CHART FOR TELESIS BIO INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.43
Previous Close
$0.38
Days Range
$0.31 - $0.46
52 week range
$0.30 - $3.01
Volume
266,587
Avg. Volume (30 days)
63,597
Market Cap
$11.44M
Dividend Yield
-
P/E
(0.24)
Shares Outstanding
30,103,284
Open
$0.43
Previous Close
$0.38
Days Range
$0.31 - $0.46
52 week range
$0.30 - $3.01
Volume
266,587
Avg. Volume (30 days)
63,597
Market Cap
$11.44M
Dividend Yield
-
P/E
(0.24)
Shares Outstanding
30,103,284
FINANCIAL STATEMENTS FOR TELESIS BIO INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TELESIS BIO INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Nelson Todd RobertChief Executive OfficerMar 01, 2024 Option Exercise$0.534,7562,511174,240Mar 05, 2024, 06:55 PM
Esser Eric EugenePresident & COOMar 01, 2024 Option Exercise$0.533,3401,76429,260Mar 05, 2024, 06:40 PM
Gibson Daniel GlennChief Technology OfficerMar 01, 2024 Option Exercise$0.53656346105,562Mar 05, 2024, 06:07 PM
Cutler RobChief Legal OfficerMar 01, 2024 Option Exercise$0.531,37672735,718Mar 05, 2024, 06:04 PM
Nelson Todd RobertPresident & CEOFeb 27, 2024 Option Exercise$0.534,7762,550131,296Feb 29, 2024, 08:15 PM
Gibson Daniel GlennChief Technology OfficerFeb 27, 2024 Option Exercise$0.532,2651,21099,818Feb 29, 2024, 08:10 PM
Cutler RobChief Legal OfficerFeb 27, 2024 Option Exercise$0.532,1741,16123,294Feb 29, 2024, 08:05 PM
Nelson Todd RobertPresident & CEOMay 04, 2023 Sale$2.832,5757,277136,072May 08, 2023, 08:11 PM
Gibson Daniel GlennChief Technology OfficerMay 04, 2023 Sale$2.831,1903,363102,083May 08, 2023, 08:09 PM
Cutler RobChief Legal OfficerMay 04, 2023 Sale$2.831,1743,31825,468May 08, 2023, 08:06 PM
Nelson Todd RobertPresident & CEONov 11, 2022 Buy$1.56122,516191,542122,516Nov 14, 2022, 04:44 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Nelson Todd RobertChief Executive Officer03/01/20242,511
Esser Eric EugenePresident & COO03/01/20241,764
Gibson Daniel GlennChief Technology Officer03/01/2024346
Cutler RobChief Legal Officer03/01/2024727
Nelson Todd RobertPresident & CEO02/27/20242,550
Gibson Daniel GlennChief Technology Officer02/27/20241,210
Cutler RobChief Legal Officer02/27/20241,161
Nelson Todd RobertPresident & CEO05/04/20237,277
Gibson Daniel GlennChief Technology Officer05/04/20233,363
Cutler RobChief Legal Officer05/04/20233,318
Nelson Todd RobertPresident & CEO11/11/2022191,542
Load More Insider Transactions
FUNDS WITH A POSITION IN TELESIS BIO INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
GEODE CAPITAL MANAGEMENT, LLC83,5610%No changeOther
RENAISSANCE TECHNOLOGIES LLC27,5470.00002%NewOther
BLACKROCK INC.25,8570%-1.15%Other
CHANGE IN SHARES OUTSTANDING FOR TELESIS BIO INC
STOCK BUYBACKS FOR TELESIS BIO INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.22%
1Q
12/31/2023
06/30/2023
0.80%
2Q
12/31/2023
03/31/2023
1.18%
3Q
12/31/2023
12/31/2022
1.51%
4Q
12/31/2023
09/30/2022
1.67%
5Q
12/31/2023
06/30/2022
1.96%
6Q
12/31/2023
03/31/2022
2.32%
7Q
12/31/2023
12/31/2021
64.70%
8Q
12/31/2023
09/30/2021
2.43%
9Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.22%
1Q
06/30/2023
0.80%
2Q
03/31/2023
1.18%
3Q
12/31/2022
1.51%
4Q
09/30/2022
1.67%
5Q
06/30/2022
1.96%
6Q
03/31/2022
2.32%
7Q
12/31/2021
64.70%
8Q
09/30/2021
2.43%
9Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR TELESIS BIO INC
LOADING...